Key result
A recombinant Coxsackievirus B3 expressing IFN-gamma activated iNOS and NO release in macrophages, reducing viral replication and protecting mice from lethal infections.
A recombinant CVB3 expressing IFN-gamma protects against lethal infection and reduces viral replication via iNOS induction in murine models, suggesting a potential strategy against virus-induced myocarditis.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for engineered CVB3 in murine myocarditis; should not yet inform human therapy.
Jarasch et al. (2005) studied Coxsackievirus B3 infection / virus-induced myocarditis. Recombinant virus variant CVB3/IFN-gamma was evaluated on Viral replication, iNOS induction, viral load reduction, and pancreatic tissue protection. A recombinant Coxsackievirus B3 expressing IFN-gamma activated iNOS and NO release in macrophages, reducing viral replication and protecting mice from lethal infections.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: